Broad Institute of MIT and Harvard

The Broad Institute is a genomic medicine research center located in Cambridge, Massachusetts, United States. Although it is independently governed and supported as a 501(c)(3) nonprofit research organization, the institute is formally affiliated with the Massachusetts Institute of Technology, Harvard University and its affiliated hospitals. The faculty and staff of the Broad Institute include physicians, geneticists, and molecular, chemical, and computational biologists.

Address
Broad Institute scientists and administrators are currently located in three buildings: 7 Cambridge Center, 5 Cambridge Center and 320 Charles Street in Cambridge, MA.
Website
http://www.broadinstitute.org/
Wikipedia
http://en.wikipedia.org/wiki/Broad_Institute

Some content from Wikipedia, licensed under CC BY-SA

Subscribe to rss feed

Diseases, Conditions, Syndromes

Study of severe COVID-19 helps uncover the roots of sepsis

Sepsis is a dreaded, life-threatening condition that can occur when an infection spins out of control. Like a tsunami after an earthquake, sepsis occurs when an infection triggers a dysregulation of the immune system, which ...

Oncology & Cancer

Tumors hide from the immune system with help from this protein

Cancer drugs called immune checkpoint inhibitors boost the immune system's ability to find and destroy tumor cells, but they don't work for most patients. Researchers at the Broad Institute of MIT and Harvard, Massachusetts ...

Diseases, Conditions, Syndromes

How B cells fight the COVID-19 virus

A study of antibody-producing B cells from patients who recovered from COVID-19 reveals a new cross-reactive antibody and what makes some B cells more effective at neutralizing the virus.

Oncology & Cancer

New maps link thousands of genetic variants to disease genes

Genome-wide association studies (GWAS) have identified thousands of genetic variants that are associated with a wide range of diseases. But these studies often fall short of establishing what a genetic variant does to bring ...

Oncology & Cancer

Pediatric cancers have unique genetic vulnerabilities

Most cancer drugs that target specific genetic mutations are designed for adult cancers rather than those in children, partly because pediatric cancers have fewer mutations. To look for more ways to target childhood cancers, ...

page 1 from 16